Treatment of Helicobacter pylori-associated lymphomas


Published: May 29, 2009
Abstract Views: 142
Untitled (): 0
PDF: 195
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The regression of gastric MALT lymphoma after antibiotic eradication of H. pylori was first reported in 1993 by Wotherspoon and colleagues, who described the efficacy of antibiotic therapy in six patients with superficially invasive gastric MALT lymphoma.1 Our and other groups thereafter confirmed the efficacy of antibiotics in inducing apparently durable lymphoma remissions: in 60-100% of patients with localized H. pylori-positive gastric MALT lymphoma.2-9 The histologic remission can usually be documented within 6 months from the H. pylori eradication but sometimes the period required is more prolonged and the therapeutic response may be delayed up to more than 1 year.10

Supporting Agencies


Zucca, E. (2009). Treatment of Helicobacter pylori-associated lymphomas. Hematology Meeting Reports (formerly Haematologica Reports), 1(5). https://doi.org/10.4081/hmr.v1i5.264

Downloads

Citations